搜索临床试验以:重组人干扰素α-1b
总计2259个结果
-
University Hospital Inselspital, BernePharmaPart; Viollier AG, Basel, Switzerland完全的
-
Hoffmann-La Roche完全的肾细胞癌 | 慢性粒细胞白血病 | 恶性黑色素瘤加拿大, 印度, 保加利亚, 俄罗斯联邦, 西班牙, 南非, 斯洛伐克
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group完全的
-
University of California, San DiegoNational Cancer Institute (NCI)完全的
-
French Innovative Leukemia Organisation完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
European Organisation for Research and Treatment...完全的
-
Novartis Pharmaceuticals完全的
-
ProtalixChiesi Farmaceutici S.p.A.完全的法布里病美国, 丹麦, 比利时, 英国, 挪威, 意大利, 捷克语
-
National Cancer Institute, MilanAssociazione Italiana per la Ricerca sul Cancro完全的
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe Ltd完全的
-
University Hospital TuebingenDermatologic Cooperative Oncology Group完全的
-
Seoul National University HospitalRoche Pharma AG; SciClone Pharmaceuticals完全的
-
Beijing Bio-Fortune Ltd.完全的
-
Children's Hospital of Fudan UniversityChanghai Hospital; Hunan Children's Hospital; Yuying Children's Hospital of Wenzhou Medical University 和其他合作者完全的
-
M.D. Anderson Cancer CenterNovartis完全的
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)暂停
-
Dermatologic Cooperative Oncology Group未知治疗 | 佐剂 | III期恶性黑色素瘤 | Interferon Alpha德国
-
Greenovation Biotech GmbHFGK Clinical Research GmbH完全的
-
Nancy Hammond, MDKansas City Area Life Sciences Institute, Inc.完全的
-
The Cleveland ClinicNational Cancer Institute (NCI)终止
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group撤销
-
Genzyme, a Sanofi Company批准上市
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)完全的
-
Royal Marsden NHS Foundation Trust完全的
-
Emory UniversityCURE Childhood Cancer, Inc.完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的